Topic: Aluminum Adjuvants

Aluminum Adjuvants comes up in 3 chapters across 2 episodes of The Higherside Chats Free Show, from December 2018 to June 2019.

December 2018 June 2019

Related topics

Wayne McRoy Jr. | The Autism Epidemic, Transhumanism, & The A.I. Agenda
• 17:48 - 22:02

Wayne McRoy Jr. | The Autism Epidemic, Transhumanism, & The A.I. Agenda

Aluminum Toxicity, Alzheimer's, and the MTHFR Gene Mutation

The discussion focuses on aluminum as a primary environmental factor in both autism and Alzheimer's disease. Wayne McRoy explains that many individuals on the spectrum possess the MTHFR gene mutation, which impairs the body's ability to methylate and eliminate heavy metals. This genetic vulnerability, combined with the ubiquity of aluminum in cans, foil, and vaccines, leads to toxic accumulation and neurological damage that manifests differently across age groups.

aluminum adjuvantsalzheimer's diseasemthfr geneheavy metalsmethylation
Wayne McRoy Jr. | The Autism Epidemic, Transhumanism, & The A.I. Agenda
• 50:00 - 52:57

Wayne McRoy Jr. | The Autism Epidemic, Transhumanism, & The A.I. Agenda

Vaccine Adjuvants and the Blood-Brain Barrier

Wayne McRoy reiterates the link between vaccines and neurological disorders, specifically pointing to aluminum adjuvants. He explains that nano-particulate aluminum, often smaller than 200 nanometers, can freely cross the blood-brain barrier and cause encephalitis. He describes this as a synergistic process where the body is overwhelmed by aluminum from multiple sources, including air, food, and medical injections.

vaccine adjuvantsaluminum nanoparticlesblood-brain barrierencephalitissynergistic toxicity
Kim Mack Rosenberg & Eileen Iorio | The HPV Vaccine On Trial, Adjuvants, & Data Manipulation
• 9:37 - 15:32

Kim Mack Rosenberg & Eileen Iorio | The HPV Vaccine On Trial, Adjuvants, & Data Manipulation

Flaws in HPV Vaccine Clinical Trials and Placebos

The guests detail how clinical trials for the HPV vaccine failed to use an inert saline placebo, instead using a proprietary aluminum adjuvant as the control. They highlight a specific case in Denmark where trial participants were allegedly misled about the nature of the placebo and suffered injuries that were not properly recorded.

clinical trialssaline placeboaluminum adjuvantfdadenmark